Discovery and Drug Development

The Discovery and Drug Development team at Sygnature Discovery Limited spearheads the identification and validation of new drug candidates. Their multidisciplinary collaboration includes experts in immunology, oncology, neuroscience, medicinal chemistry, and DMPK to drive the early stages of drug discovery, optimize lead compounds, and advance promising candidates through preclinical development.